Page last updated: 2024-10-31

apnea and Neuroleptic Malignant Syndrome

apnea has been researched along with Neuroleptic Malignant Syndrome in 2 studies

Apnea: A transient absence of spontaneous respiration.

Neuroleptic Malignant Syndrome: A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Greenwood, M1
Meechan, JG1
Shintani, S1
Shiigai, T1
Tsuchiya, K1
Kikuchi, M1

Other Studies

2 other studies available for apnea and Neuroleptic Malignant Syndrome

ArticleYear
General medicine and surgery for dental practitioners. Part 2--metabolic disorders.
    British dental journal, 2010, May-08, Volume: 208, Issue:9

    Topics: Amyloidosis; Anesthetics, Local; Apnea; Carbohydrate Metabolism, Inborn Errors; Dental Care for Chro

2010
Hyperventilation alternating with apnea in neuroleptic malignant syndrome associated with metoclopramide and cisapride.
    Journal of the neurological sciences, 1995, Volume: 128, Issue:2

    Topics: Aged; Apnea; Brain; Cisapride; Fatal Outcome; Humans; Hyperventilation; Male; Metoclopramide; Neurol

1995